PPARA and Hepatic steatosis: Additionally, these points could be associated with no change in WW, or even a decrease in the expression of PPAR-α, in the AW group [43,44], which is likely related to hepatic steatosis [45,46] or enhanced lipid oxidation or ketogenesis, suggested by increased 3-hydroxybutyrate in the WW group.